Cyclease Menopause Tablet
NDC Package 0220-9082-04

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Cyclease Menopause (arnica montana whole, black cohosh, nitroglycerin, lachesis muta venom, sanguinaria canadensis root) tablets is temporarily relieves symptoms associated with perimenopause and menopause such as: hot flashes, red, blotchy or flushed face, night sweats, mood changes, irritability, occasional sleeplessness, temporarily reduces the intensity and frequency of hot flashes associated with perimenopause and menopause. This formulation utilizes a tablet delivery system. Marketed by Boiron, this product is identified by NDC 0220-9082.

Identification & Billing

NDC Package Code
0220-9082-04
Package Description
60 BLISTER PACK in 1 CARTON / 60 TABLET in 1 BLISTER PACK
Product Code
0220-9082
11-Digit Billing Format
00220908204

Clinical Specifications

Proprietary Name
Cyclease Menopause
Non-Proprietary Name
Arnica Montana Whole, Black Cohosh, Nitroglycerin, Lachesis Muta Venom, Sanguinaria Canadensis Root
Substance Name
Arnica Montana Whole; Black Cohosh; Lachesis Muta Venom; Nitroglycerin; Sanguinaria Canadensis Root
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Temporarily relieves symptoms associated with perimenopause and menopause such as: hot flashes, red, blotchy or flushed face, night sweats, mood changes, irritability, occasional sleeplessness, temporarily reduces the intensity and frequency of hot flashes associated with perimenopause and menopause

Regulatory & Marketing

Labeler Name
Boiron
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
04-01-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0220-9082-04 identifies a specific commercial package of 60 blister pack in 1 carton / 60 tablet in 1 blister pack of Cyclease Menopause, a human over the counter drug labeled by Boiron. This tablet is formulated for oral use and contains arnica montana whole; black cohosh; lachesis muta venom; nitroglycerin; sanguinaria canadensis root as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Boiron on April 01, 2020. The current certification is valid through December 31, 2026.

How is this Boiron product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00220908204. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0220-9082-04
11-Digit CMS (5-4-2)
00220-9082-04

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.